skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Pheochromocytomas and pituitary adenomas in three patients with MAX exon deletions

Endocrine-related cancer, 2018-05, Vol.25 (5), p.L37-L42 [Peer Reviewed Journal]

2018 Society for Endocrinology ;ISSN: 1351-0088 ;ISSN: 1479-6821 ;EISSN: 1479-6821 ;DOI: 10.1530/ERC-18-0065 ;PMID: 29535143

Full text available

Citations Cited by
  • Title:
    Pheochromocytomas and pituitary adenomas in three patients with MAX exon deletions
  • Author: Daly, Adrian F ; Castermans, Emilie ; Oudijk, Lindsey ; Guitelman, Mirtha A ; Beckers, Pablo ; Potorac, Iulia ; Neggers, Sebastian J C M M ; Sacre, Nathalie ; van der Lely, Aart-Jan ; Bours, Vincent ; de Herder, Wouter W ; Beckers, Albert
  • Subjects: Endocrinologie, métabolisme & nutrition ; Endocrinology, metabolism & nutrition ; Human health sciences ; Sciences de la santé humaine
  • Is Part Of: Endocrine-related cancer, 2018-05, Vol.25 (5), p.L37-L42
  • Description: Copy number variations (CNV), an important genetic mechanism in inherited tumor genetics, can affect large genetic regions or can be limited to smaller regions within genes, such deletions of single exons. Such exon deletions can be challenging to identify and sequencing can be normal in these cases. Multiplex ligation dependent probe amplification (MLPA) can identify CNV of individual exons. Mutations in the MAX gene are associated with a risk of sporadic and hereditary pheochromocytoma. As mutations in other pheochromocytoma related genes can also cause pituitary tumors (3P-Association), we studied whether MAX exon deletions were involved in the etiology of patients with an unexplained association of multiple endocrine neoplasia including pituitary adenoma and pheochromocytoma. Using MLPA we identified three patients with pheochromocytoma and pituitary adenomas who had normal MAX sequencing but presented germline heterozygous MAX exon deletions. The three patients had either acromegaly (n=2) or prolactinoma (n=1) in association with bilateral or recurrent pheochromocytoma. Two had germline heterozygous deletions of single exons of MAX, the other had a germline heterozygous deletion of MAX exons 1-3. MAX immunohistochemical staining was lost in the pheochromocytomas of all three patients and genetic analysis confirmed loss of heterozygosity in tumor DNA. A MAX exon deletion was also transmitted from one patient to a currently asymptomatic offspring. Screening studies of pheochromocytoma patients should take into account the potential for co-existing pituitary tumors. MLPA or other techniques to identify discrete MAX exon deletions should be considered in individuals with pheochromocytoma that are negative following comprehensive sequencing.
  • Publisher: England: Bioscientifica Ltd
  • Language: English
  • Identifier: ISSN: 1351-0088
    ISSN: 1479-6821
    EISSN: 1479-6821
    DOI: 10.1530/ERC-18-0065
    PMID: 29535143
  • Source: Freely Accessible Journals
Back to results list
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait